Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Federica Bianchi.
British Journal of Pharmacology | 2003
Giovanni Appendino; Selena Harrison; Luciano De Petrocellis; Nives Daddario; Federica Bianchi; Aniello Schiano Moriello; Marcello Trevisani; Francesca Benvenuti; Pierangelo Geppetti; Vincenzo Di Marzo
The C‐5 halogenation of the vanillyl moiety of resiniferatoxin, an ultrapotent agonist of vanilloid TRPV1 receptors, results in a potent antagonist for these receptors. Here, we have synthesized a series of halogenated derivatives of ‘synthetic capsaicin’ (nonanoyl vanillamide=nordihydrocapsaicin) differing for the nature (iodine, bromine–chlorine) and the regiochemistry (C‐5, C‐6) of the halogenation. The activity of these compounds was investigated on recombinant human TRPV1 receptors overexpressed in HEK‐293 cells. None of the six compounds exerted any significant agonist activity, as assessed by measuring their effect on TRPV1‐mediated calcium mobilization. Instead, all compounds antagonized, to various extents, the effect of capsaicin in this assay. All 6‐halo‐nordihydrocapsaicins behaved as competitive antagonists against human TRPV1 according to the corresponding Schilds plots, and were more potent than the corresponding 5‐halogenated analogues. The iodo‐derivatives were more potent than the bromo‐ and chloro‐derivatives. Using human recombinant TRPV1, 6‐iodo‐nordihydrocapsaicin (IC50=10 nM against 100 nM capsaicin) was about four times more potent than the prototypical TRPV1 antagonist, capsazepine, and was tested against capsaicin also on native TRPV1 in: (i) rat dorsal root ganglion neurons in culture; (ii) guinea‐pig urinary bladder; and (iii) guinea‐pig bronchi. In all cases, except for the guinea‐pig bronchi, the compound was significantly more potent than capsazepine as a TRPV1 antagonist. In conclusion, 6‐iodo‐nordihydrocapsaicin, a stable and easily prepared compound, is a potent TRPV1 antagonist and a convenient replacement for capsazepine in most of the in vitro preparations currently used to assess the activity of putative vanilloid receptor agonists.
Free Radical Research | 2003
Antonella Rosa; Monica Deiana; Casu; G Corona; Giovanni Appendino; Federica Bianchi; Mauro Ballero; Ma Dessì
The use of myrtle (Myrtus communis L.) as a culinary spice and as a flavoring agent for alcoholic beverages is widespread in the Mediterranean area, and especially in Sardinia. Myrtle contains unique oligomeric non-prenylated acylphloroglucinols, whose antioxidant activity was investigated in various systems. Both semimyrtucommulone (1) and myrtucommulone A (2) showed powerful antioxidant properties, protecting linoleic acid against free radical attack in simple in vitro systems, inhibiting its autoxidation and its FeCl3- and EDTA-mediated oxidation. While both compounds lacked pro-oxidant activity, semimyrtucommulone was more powerful than myrtucommulone A, and was further evaluated in rat liver homogenates for activity against lipid peroxidation induced by ferric-nitrilotriacetate, and in cell cultures for cytotoxicity and the inhibition of TBH- or FeCl3-induced oxidation. The results of these studies established semimyrtucommulone as a novel dietary antioxidant lead.
Phytochemistry | 2003
Luisa Pistelli; Cecilia Noccioli; Giovanni Appendino; Federica Bianchi; Olov Sterner; Mauro Ballero
The aerial parts of Mediterranean papilionaceous plants Bituminaria morisiana and B. bituminosa afforded, along with known phenolics, the prenylated pterocarpans bitucarpin A and B, whose structure was elucidated by spectroscopic techniques. A known isoflavonoid (8-prenyldaidzein) was also obtained for the first time as a genuine plant constituent. The accumulation of pterocarpans at the expense of biogenetically more primitive shikimate metabolites like furanocoumarins or isoflavonoids supports the inclusion of this plant, once part of the genus Psoralea, into the distinct genus Bituminaria.
British Journal of Pharmacology | 2003
Giovanni Appendino; Selena Harrison; Luciano De Petrocellis; Nives Daddario; Federica Bianchi; Aniello Schiano Moriello; Marcello Trevisani; Francesca Benvenuti; Pierangelo Geppetti; Vincenzo Di Marzo
British Journal of Pharmacology (2003) 140, 1008. doi:10.1038/sj.bjp.0705565
Journal of Natural Products | 2007
Giovanni Appendino; Michela Ottino; Nieves Marquez; Federica Bianchi; Anna Giana; Mauro Ballero; Olov Sterner; Bernd L. Fiebich; Eduardo Muñoz
Journal of Natural Products | 2002
Giovanni Appendino; Federica Bianchi; Alberto Minassi; Olov Sterner; Mauro Ballero; Simon Gibbons
Organic Letters | 2002
Giovanni Appendino; Alberto Minassi; Nives Daddario; Federica Bianchi; Gian Cesare Tron
Journal of Natural Products | 2002
Luisella Verotta; Giovanni Appendino; Emanuela Belloro; Federica Bianchi; Olov Sterner; Marco Lovati; Ezio Bombardelli
Journal of Natural Products | 2004
Giovanni Appendino; Federica Bianchi; Ammar Bader; Claudio Campagnuolo; Ernesto Fattorusso; Orazio Taglialatela-Scafati; Magdalena Blanco-Molina; Antonio Macho; Bernd L. Fiebich; Paul Bremner; Michael Heinrich; Mauro Ballero; Eduardo Muñoz
23nd IUPAC Symposium on Natural Products Chemistry | 2002
Luisella Verotta; E. Di Teodoro; Giovanni Appendino; Federica Bianchi; Olov Sterner; N. Fuzzati; J.-L. Wolfender; Ezio Bombardelli